84 studies found for:
abiraterone
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male Participants
|
||||
| 2 | Completed |
A Comparative Study of Bioavailability of 3 New Abiraterone Acetate Tablets With Current Commercial Tablet
|
||||
| 3 | Completed |
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men
|
||||
| 4 | Completed |
A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants
|
||||
| 5 | Completed |
A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Men
|
||||
| 6 | Recruiting |
A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
|
||||
| 7 | Recruiting |
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
|
||||
| 8 | Recruiting |
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy
|
||||
| 9 | Not yet recruiting |
Phase II Study of ABT-263/Abiraterone or ABT-263/Abiraterone/Hydroxychloroquine in Prostrate Cancer
|
||||
| 10 | Recruiting |
A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer
|
||||
| 11 | Active, not recruiting |
A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
|
||||
| 12 | Completed |
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer
|
||||
| 13 | Completed |
A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function
|
||||
| 14 | Completed |
A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer
|
||||
| 15 | Completed |
A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
|
||||
| 16 | Recruiting |
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
|
||||
| 17 | Not yet recruiting |
Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
|
||||
| 18 | Completed |
Abiraterone Acetate in Patients With Prostate Cancer Who Have Failed Hormone Therapy
|
||||
| 19 | Recruiting |
Abiraterone Acetate Trial in African American Prostate Cancer Patients
|
||||
| 20 | Recruiting |
A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
|
† Indicates status has not been verified in more than two years
